STOCK TITAN
  1. Home
  2. Sec-filings
  3. CAVA
  4. [Form 4] CAVA GROUP, INC. Insider Trading Activity

CAVA (NYSE: CAVA) director sells 10,000 shares after exercising stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CAVA GROUP, INC. director Karen Kochevar reported a combination of option exercises and share sales in Common Stock. On 2026-06-18, she exercised stock options to acquire a total of 10,000 shares at strike prices ranging from $2.94 to $9.58 per share. That same day, she executed an open-market sale of 10,000 shares at $90.00 per share. Following these transactions, she directly holds 3,074 shares of CAVA Common Stock.

Positive

  • None.

Negative

  • None.

Insights

Routine option exercise paired with an offsetting sale, modest in scale.

Director Karen Kochevar exercised stock options for 10,000 CAVA shares at strike prices between $2.94 and $9.58, then sold 10,000 shares at $90.00 in an open-market transaction on 2026-06-18. This pattern is typical of insiders converting options and taking liquidity.

After the transactions, she directly holds 3,074 CAVA shares, indicating a relatively small remaining position. The filing shows no remaining derivative positions in the summarized data, and the footnote confirms the options involved were fully vested and exercisable. Overall, this looks like a routine monetization of equity compensation rather than a thesis-changing move.

Insider KOCHEVAR KAREN
Role null
Sold 10,000 shs ($900K)
Type Security Shares Price Value
Exercise Stock Options (right to buy) 625 $0.00 --
Exercise Stock Options (right to buy) 1,875 $0.00 --
Exercise Stock Options (right to buy) 3,750 $0.00 --
Exercise Stock Options (right to buy) 3,750 $0.00 --
Exercise Common Stock 625 $2.94 $2K
Exercise Common Stock 1,875 $3.12 $6K
Exercise Common Stock 3,750 $6.25 $23K
Exercise Common Stock 3,750 $9.58 $36K
Sale Common Stock 10,000 $90.00 $900K
Holdings After Transaction: Stock Options (right to buy) — 6,875 shares (Direct, null); Common Stock — 3,699 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares sold 10,000 shares Open-market sale of Common Stock at $90.00 on June 18, 2026
Sale price $90.00 per share Price for 10,000 Common Stock shares sold June 18, 2026
Options exercised 10,000 shares Total Common Stock from option exercises on June 18, 2026
Highest option strike $9.58 per share Exercise price for 3,750 underlying shares
Lowest option strike $2.94 per share Exercise price for 625 underlying shares
Shares held after sale 3,074 shares Direct Common Stock holdings following transactions
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
Stock Options (right to buy) financial
"security_title": "Stock Options (right to buy)""
fully vested and exercisable financial
"shares subject to this option are fully vested and exercisable"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KOCHEVAR KAREN
(Last)(First)(Middle)
C/O CAVA GROUP, INC.
14 RIDGE SQUARE NW, SUITE 500
(Street)
WASHINGTON DISTRICT OF COLUMBIA 20016
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
CAVA GROUP, INC. [ CAVA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/18/2026M625A$2.943,699D
Common Stock06/18/2026M1,875A$3.125,574D
Common Stock06/18/2026M3,750A$6.259,324D
Common Stock06/18/2026M3,750A$9.5813,074D
Common Stock06/18/2026S10,000D$903,074D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (right to buy)$2.9406/18/2026M625 (1)12/13/2029Common Stock625$06,875D
Stock Options (right to buy)$3.1206/18/2026M1,875 (1)08/01/2030Common Stock1,875$00D
Stock Options (right to buy)$6.2506/18/2026M3,750 (1)08/01/2031Common Stock3,750$00D
Stock Options (right to buy)$9.5806/18/2026M3,750 (1)01/24/2033Common Stock3,750$01,875D
Explanation of Responses:
1. All of the shares subject to this option are fully vested and exercisable as of the date hereof.
Remarks:
/s/ Amit Patel, as Attorney-in-Fact06/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did CAVA (CAVA) director Karen Kochevar report?

Karen Kochevar reported exercising options for 10,000 CAVA shares and selling 10,000 shares. On 18 June 2026, she exercised multiple stock options, then executed an open-market sale of 10,000 Common Stock shares at $90.00 per share.

How many CAVA (CAVA) shares did Karen Kochevar sell and at what price?

She sold 10,000 CAVA Common Stock shares at $90.00 per share. The transaction was reported as an open-market sale, classified under code "S" on the Form 4, indicating a standard sale in the market or a private transaction.

What stock options did Karen Kochevar exercise in this CAVA (CAVA) filing?

She exercised stock options covering 10,000 CAVA shares at strike prices from $2.94 to $9.58. The options had exercise prices of $9.58, $6.25, $3.12, and $2.94 per share, all fully vested and exercisable as of the transaction date.

How many CAVA (CAVA) shares does Karen Kochevar hold after these transactions?

After the reported transactions, she directly holds 3,074 CAVA Common Stock shares. This post-transaction holding figure comes from the open-market sale entry, which lists total shares following the transaction as 3,074.

Were Karen Kochevar’s CAVA (CAVA) options fully vested before exercise?

Yes, the options exercised were fully vested and exercisable. A footnote in the filing states that all shares subject to the option were fully vested and exercisable as of the transaction date, supporting the timing of the exercises and related sale.

Does Karen Kochevar’s CAVA (CAVA) Form 4 show net buying or net selling?

The Form 4 shows a net-sell position of 10,000 shares. While she acquired 10,000 shares through option exercises, she also sold 10,000 shares in the market, and the transaction summary characterizes this as net selling overall.